Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions
Katarzyna Szklener(Medical University of Lublin), Sławomir Mańdziuk(Medical University of Lublin)
Cited by 43
Related Papers
Phase 2 study of retifanlimab (INCMGA00012) in patients (pts) with selected solid tumors (POD1UM-203).
|Journal of Clinical Oncology|2021|7